Product containing precisely darifenacin (as darifenacin hydrobromide) 7.5 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 38894211000001109 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
775453002Darifenacin
product
10363801000001108Virtual medicinal product
product
43814611000001107Darifenacin 7.5mg modified-release tablets (A A H Pharmaceuticals Ltd)
real clinical drug
43158411000001102Darifenacin 7.5mg modified-release tablets (Accord-UK Ltd)
real clinical drug
43537711000001101Darifenacin 7.5mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
real clinical drug
42871711000001101Darifenacin 7.5mg modified-release tablets (Aristo Pharma Ltd)
real clinical drug
37435911000001105Emselex 7.5mg modified-release tablets (CST Pharma Ltd)
real clinical drug
38132711000001109Emselex 7.5mg modified-release tablets (DE Pharmaceuticals)
real clinical drug
37634511000001102Emselex 7.5mg modified-release tablets (Ethigen Ltd)
real clinical drug
37408011000001106Emselex 7.5mg modified-release tablets (Mawdsley-Brooks & Company Ltd)
real clinical drug
36798911000001101Emselex 7.5mg modified-release tablets (Originalis B.V.)
real clinical drug
10968011000001104Emselex 7.5mg modified-release tablets (pharmaand GmbH)
real clinical drug